Published in Gene Therapy Weekly, September 19th, 2002
Ricerca Biosciences also announced the launch of its infectious diseases program by in-licensing from Genset the entire genomic sequences of Chlamydia pneumoniae and Chlamydia trachomatis, two important pathogenic bacteria.
Robert C. Moellering, Jr., is the Herrman L. Blumgart professor of medicine at Harvard Medical School and physician-in-chief and chairman of the department of medicine at the Beth Israel...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.